Zobrazeno 1 - 6
of 6
pro vyhledávání: '"A E, Zdorov"'
Publikováno v:
Российский кардиологический журнал, Vol 29, Iss 2S (2024)
The article presents a case of immunoglobulin light chain amyloidosis with cardiac involvement without typical noncardiac manifestations. A complex diagnostic search for the cause of newly diagnosed pulmonary hypertension is described. Aspects of dif
Externí odkaz:
https://doaj.org/article/c0fc180c92734d47b95edd85e245d7e3
Autor:
I. S Skopets, N. N Vezikova, A. N Malygin, A. V Malafeev, A. E Zdorov, A. V Leont'ev, M. I Sidorova
Publikováno v:
КардиоСоматика, Vol 8, Iss 1 (2017)
Цель. Оценить приверженность терапии, клинические последствия и летальность в отдаленном периоде после перенесенного острого коронарн
Externí odkaz:
https://doaj.org/article/afdd5654305741daa24b157344ea9653
Publikováno v:
КардиоСоматика, Vol 8, Iss 1, Pp 87-88 (2017)
Ревматоидный артрит (РА) и псориатический артрит (ПсА) имеют различные клинические проявления и иммунопатологические механизмы развити
Externí odkaz:
https://doaj.org/article/992946afb1124e1eb63157b77451095c
Publikováno v:
Terapevticheskii arkhiv. 73(5)
To study efficiency in rheumatoid arthritis (RA) of local radiotherapy methods: radionuclide synovectomy (RS), x-ray therapy (XRT) and local gamma-therapy (LGT) proposed by the authors.175 patients with RA received local radiotherapy on the knee join
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::72e03ad37c14d4c0e57015c83e9b530c
https://pubmed.ncbi.nlm.nih.gov/11517740
https://pubmed.ncbi.nlm.nih.gov/11517740
Autor:
Boris V. Afanasyev, Ruslana V Kruglina, Igor A. Lisukov, Artur E Zdorov, Gary J Gorodokin, Denis A. Fedorenko, Roman I Ivanov, Alexandr A. Myasnikov, Oleg A. Rykavicin, Tatiana I. Ionova, Anton V. Kishtovich, Andrei A. Novik, Vladimir Y. Melnichenko, Nina E. Osipova
Publikováno v:
Blood. 112:4432-4432
Conventional therapies do not provide satisfactory control of multiple sclerosis (MS) due to their inability to eradicate self-specific T cell clones. During the last decade high-dose immunosuppressive therapy (HDIT) with autologous haematopoietic st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2a4f99ec1f8a2cc0e92d30a95000742
https://doi.org/10.1182/blood.v112.11.4432.4432
https://doi.org/10.1182/blood.v112.11.4432.4432
Autor:
Andrey E. Zdorov, Boris V. Afanasiev, Inna V. Vereschagina, Yury N. Fedotov, Oleg A. Rykavicin, Olga A. Malysheva, Yury L. Shevchenko, Tatiana I. Ionova, Anton V. Kishtovich, Andrei A. Novik, Alexey N. Kuznetcov, Alexandr A. Myasnikov, Gary I. Gorodokin, Roman Ivanov, Nikolay I. Baziy, Igor A. Lisukov, Denis A. Fedorenko, Andrey D. Kulagin, Sergey V. Shamanski, Vladimir Y. Melnichenko
Publikováno v:
Blood. 108:3072-3072
During the last decade HDCT+ASCT is more often used as a therapeutic option for MS patients. The major treatment outcomes for MS patients are disease-progressive free period and improvement of patient’s quality of life (QoL). We aimed to study trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a17da5256087bd6d3e8c766f892a2af2
https://doi.org/10.1182/blood.v108.11.3072.3072
https://doi.org/10.1182/blood.v108.11.3072.3072